Apyx Medical Corp — Major Shareholding Notification 2000

Mar 31, 2000

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13D Under the Securities Exchange Act of 1934 (Amendment No. 2__ ) BOVIE MEDICAL CORPORATION - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock - -------------------------------------------------------------------------------- (Title of Class of Securities) 10211F 10 0 -------------------------- (CUSIP Number) Mr. Eric Rainer Bashford Irwin A. Kishner, Esq. 2689 Strang Boulevard Herrick, Feinstein LLP Yorktown Heights, New York 10598 2 Park Avenue Tel.: (914) 572-4327 New York, New York 10016 Tel.: (212) 592-1400 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) March 16, 2000 ---------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ]. The remainder of this cover page shall be filed out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (Continued on following page(s)) Page 1 of 4 Pages ___________ CUSIP No. 10211F100 13D Page 2 of 4 Pages ___________ 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Eric Rainer Bashford Charitable Remainder Unitrust ___________ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] ___________ 3 SEC USE ONLY ___________ 4 SOURCE OF FUNDS ___________ 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] ___________ 6 CITIZENSHIP OR PLACE OF ORGANIZATION ___________ | | NUMBER OF | 7 | SOLE VOTING POWER SHARES | | 904,000 BENEFICIALLY |_|________ OWNED BY | | EACH | 8 | SHARED VOTING POWER REPORTING | | -0- PERSON ||________ WITH | | | 9 | SOLE DISPOSITIVE POWER | | 904,000 ||________ | | | 10 | SHARED DISPOSITIVE POWER | | -0- __|_|_________ 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 904,000 ____________ 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] ___________ 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 6.13% ___________ 14 TYPE OF REPORTING PERSON ________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7 (INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION PART II TO SCHEDULE 13D This statement constitutes Amendment No. 2 to the statement on Schedule 13D filed with the Securities and Exchange Commission on February 19, 1998 (the "Original Statement"). All defined terms hereunder have the meanings set forth in the Original Statement. This Amendment No. 2 reflects certain material changes in the information set forth in the Original Statement, as amended as of March 10, 1999, as follows: Item 1. Security and Issuer Shares of Common Stock Bovie Medical Corporation 734 Walt Whitman Road Suite 207 Melville, New York 11747 (hereinafter, the "Issuer") Item 5. Interest in Securities of the Issuer (a) Prior to March 16, 2000, the Trust was the beneficial owner of 980,000 shares of Common Stock of the Issuer (the "Trust Shares"), representing 6.65% of the Issuer's Common Stock. The Trust has sold a total of 76,000 of the Trust Shares in a series of related transactions described in item 5(c) below. (c) In a series of related transactions, concluding on March 16, 2000, the Trust sold 76,000 shares of the Issuer's Common Stock for cash at an average price per share equal to $0.93. Such transactions were made pursuant to Rule 144. Item 6. Contracts, Arrangements, Understandings of Relationships With Respect to Securities of the Issuer None. Item 7. Exhibits None Page 3 of 4 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. March 31, 2000 By: /s/ Eric Rainer Bashford - ---------------------- -------------------------------- Date Eric Rainer Bashford Page 4 of 4 Pages